CDC Confirms Human Case of H5 Bird Flu in Missouri

The Centers for Disease Control and Prevention (CDC) has confirmed a human case of avian influenza A(H5) in Missouri, marking the first time the national seasonal flu surveillance system has identified the virus. The patient, who had underlying medical conditions, was hospitalized, treated with antiviral medications, and has since recovered. According to the CDC, this is the 14th human case of H5 reported in the United States in 2024 and the first instance without a known occupational exposure to infected animals.

Did You Know? This is the first human case of H5 detected in the U.S. through the national seasonal flu surveillance system.

How the Case Was Identified

The Missouri Department of Health and Senior Services (DHSS) identified the infection after a patient’s specimen tested positive for influenza A but negative for seasonal subtypes. This specific result triggered additional testing protocols. The specimen was subsequently forwarded to the CDC for confirmatory testing, which was finalized on September 5, 2024. While the patient has recovered, the Missouri DHSS is currently leading an investigation into the source of the infection, as there is no immediate known animal exposure.

View this post on Instagram about Expert Insight

From Instagram — related to Expert Insight

Why the Lack of Animal Exposure Matters

The absence of a clear animal contact distinguishes this case from previous 2024 reports. While H5 outbreaks have occurred in Missouri’s commercial and backyard poultry flocks this year, and H5N1 has been found in wild birds, the direct link to this patient remains unknown. According to the CDC, while rare, there have been novel influenza A cases where an animal source could not be identified. The primary objective of the ongoing investigation is to ensure that no onward transmission is occurring among the patient’s close contacts.

CDC confirms first human case of bird flu in Missouri

Expert Insight: The transition from targeted surveillance to detection via the general seasonal flu system is a significant indicator of how health agencies are broadening their net. The stakes involve distinguishing between isolated, sporadic infections and broader viral circulation. Because the patient had no known animal contact, the investigation’s focus on ruling out human-to-human transmission is the most critical step in assessing whether current public health guidance needs to be adjusted.

What May Happen Next

The CDC is currently performing genome sequencing on the virus and attempting to identify the neuraminidase (the “N” component) of the strain. These results could clarify the virus’s origin and potential behavior. The agency’s current assessment is that the risk to the general public from H5N1 remains low. Findings from the ongoing investigation will inform whether guidance changes are needed.

Frequently Asked Questions

Is there an ongoing outbreak in Missouri?
No. The CDC reports that there is no sign of unusual influenza activity in people in Missouri or elsewhere, and no ongoing transmission has been identified among the patient’s close contacts.

How is this case different from other H5 cases in 2024?
This is the 14th case of H5 in the U.S. this year, but it is the first to be identified without a known occupational exposure to sick or infected animals.

Has the CDC changed its health recommendations?
No. The CDC’s recommendations regarding the H5 virus remain unchanged, and the agency currently maintains that the risk to the general public remains low.

Given the nature of these findings, what steps should individuals prioritize when monitoring for respiratory symptoms during the upcoming flu season?